Radiopharmaceuticals : progress and clinical perspectives /

Radiopharmaceuticals : progress and clinical perspectives /

42

Bibliográfalaš dieđut
Váldodahkki:	Fritzberg, Alan R.
Materiálatiipa:
Almmustuhtton:	Boca Raton, Fla. : CRC Pr, 1986
Fáttát:	Radiopharmaceuticals

Geahča maid

Radiopharmaceuticals for positron emission tomography /
Dahkki: Scott, Peter J. H., et al.
Almmustuhtton: (c201)

Radiopharmaceuticals and other compounds labelled with shortlived radionuclides /
Dahkki: Welch, Michael J.
Almmustuhtton: (1977)

Radiopharmaceutical extravasations: a twenty year mini-review
Dahkki: Dustin R. Osborne
Almmustuhtton: (2023-07-01)

Radiopharmaceuticals from generator-produced radionuclides
Dahkki: International Atomic Energy Agency
Almmustuhtton: (1971)

Adverse reactions to radiopharmaceuticals
Dahkki: María del Val Gómez-Martínez, et al.
Almmustuhtton: (2021-05-01)

Brief Analysis of the Validation of Analytical Methods for Radiopharmaceuticals
Dahkki: Mengyi CHEN, et al.
Almmustuhtton: (2024-12-01)

Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
Dahkki: D. V. Goryachev, et al.
Almmustuhtton: (2025-02-01)

Regulation of Radiopharmaceutical Products
Dahkki: V. V. Kosenko, et al.
Almmustuhtton: (2022-12-01)

Pharmacokinetic Studies of Radiopharmaceuticals
Dahkki: A. S. Lunev, et al.
Almmustuhtton: (2022-12-01)

TO THE QUESTION OF RADIATION PROTECTION ENSURING OF PASSENGERS TAKEN RADIOPHARMACEUTICALS DURING TRANSPORTATION BY RAILWAY TRANSPORT
Dahkki: N. N. Artemyeva, et al.
Almmustuhtton: (2015-08-01)

Analytical and chromatographic technigues in radiopharmaceutical chemistry /
Dahkki: Wieland, Donald M., et al.
Almmustuhtton: (1986)

An overview of current phase 3 radiopharmaceutical therapy clinical trials
Dahkki: Nicolas Lepareur, et al.
Almmustuhtton: (2025-02-01)

Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions
Dahkki: Sara Calistri, et al.
Almmustuhtton: (2024-10-01)

Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
Dahkki: G. E. Kodina, et al.
Almmustuhtton: (2022-10-01)

The main issues of quality assurance of radiopharmaceuticals
Dahkki: G. E. Kodina, et al.
Almmustuhtton: (2019-12-01)

Concentration of Rhenium-188 for the Radiopharmaceutical Synthesis
Dahkki: A. O. Malysheva, et al.
Almmustuhtton: (2022-11-01)

QUALITY CONTROL OF RADIOPHARMACEUTICALS IN MEDICAL INSTITUTIONS
Dahkki: G. E. Kodina, et al.
Almmustuhtton: (2019-01-01)

RADIOPHARMACEUTICALS BASED ON THE GLUCOSE DERIVATIVES FOR TUMOR DIAGNOSIS
Dahkki: R. V. Zeltchan, et al.
Almmustuhtton: (2018-05-01)

Non-clinical Studies of Radiopharmaceuticals: Analysis of National and International Regulatory Practice (Review)
Dahkki: O. E. Klementyeva, et al.
Almmustuhtton: (2024-07-01)

Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions
Dahkki: Ajnas Alkatheeri, et al.
Almmustuhtton: (2025-02-01)

SYNTHESIS OF RADIOPHARMACEUTICAL WITH RHENIUM-188 AND LIPIODOL
Dahkki: G. E. Kodina, et al.
Almmustuhtton: (2019-01-01)

Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals
Dahkki: O. E. Klementyeva, et al.
Almmustuhtton: (2021-12-01)

Selection and Use of Antioxidants-radioprotectors in the Composition of Therapeutic Radiopharmaceuticals (Review)
Dahkki: E. P. Pavlenko, et al.
Almmustuhtton: (2023-12-01)

Analysis of Current Rules and Regulations for Preclinical Studies of Radiopharmaceuticals
Dahkki: A. S. Lunev, et al.
Almmustuhtton: (2024-02-01)

Peculiarities of the Regulatory Status of Radiopharmaceuticals Manufactured in Medical Organisations
Dahkki: S. V. Shatik, et al.
Almmustuhtton: (2022-12-01)

Non-[<sup>18</sup>F]FDG PET-Radiopharmaceuticals in Oncology
Dahkki: Antonia Dimitrakopoulou-Strauss, et al.
Almmustuhtton: (2024-12-01)

Operational guidance on hospital radiopharmacy : a safe and effective approach [electronic resource] /
Dahkki: International Atomic Energy Agency
Almmustuhtton: (2008)

Operational guidance on hospital radiopharmacy : a safe and effective approach /
Dahkki: International Atomic Energy Agency
Almmustuhtton: (2008)

Radiosynthesis and Preclinical Evaluation of [<sup>99m</sup>Tc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections
Dahkki: Syeda Marab Saleem, et al.
Almmustuhtton: (2024-09-01)

Radiation Absorbed Dose Evaluation of [177Lu] Lu-DOTMP Radiopharmaceutical in Man Based On Biodistribution Data in Wistar Rats
Dahkki: Reza Bagheri, et al.
Almmustuhtton: (2024-12-01)

Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
Dahkki: A. O. Malysheva, et al.
Almmustuhtton: (2020-12-01)

Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies
Dahkki: Fucen Liu, et al.
Almmustuhtton: (2025-03-01)

Can ChatGPT help patients understand radiopharmaceutical extravasations?
Dahkki: Madeleine Alvarez
Almmustuhtton: (2024-11-01)

[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors
Dahkki: Alexis M. Sanwick, et al.
Almmustuhtton: (2024-12-01)

Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling
Dahkki: Aryan Golzaryan, et al.
Almmustuhtton: (2025-02-01)

Results of individual dosimetric monitoring of the hands skin for personnel engaged in working with radiopharmaceuticals
Dahkki: E. N. Shleenkova, et al.
Almmustuhtton: (2025-01-01)

About the requirements of regular monitoring of doses for the eye lens of the staff working with radiopharmaceuticals
Dahkki: E. N. Shleenkova, et al.
Almmustuhtton: (2021-10-01)

An Insight to Nanoliposomes as Smart Radiopharmaceutical Delivery Tools for Imaging Atherosclerotic Plaques: Positron Emission Tomography Applications
Dahkki: Reabetswe Sebatana, et al.
Almmustuhtton: (2025-02-01)

Radioactivity distribution in the blood and urine of patients receiving systemic therapy with a <sup>177</sup>Lu radiopharmaceutical and local (intra-articular) therapy with a <sup>188</sup>Re radiopharmaceutical
Dahkki: E. D. Stepchenkova, et al.
Almmustuhtton: (2022-12-01)

Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
Dahkki: Laura De Nardo, et al.
Almmustuhtton: (2024-11-01)